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1. Many surveys of dermatological 
conditions in patients 
with diabetes have been 
undertaken and xerosis is 
commonly reported.
2. Complex biochemical changes 
that result from hyperglycaemia 
may contribute to the 
development of xerosis.
3. Emollients are known to be 
effective in the management 
of dry skin and are 
recommended as part of the 
routine foot care regimen 
in people with diabetes.
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Dry skin (anhidrosis, xerosis) commonly affects the feet of many patients. In a 
people with diabetes, dry skin has the potential to progress to cracking and fissuring 
creating a portal of entry for bacteria. The causes of the dry skin are varied and often 
multifactorial. Research evidence investigating the management of this condition using 
emollients is limited to a few small scale studies coupled with clinical experience. 
This paper will review how dry skin may develop, focussing on the diabetic foot, and 
suggest an approach to managing this common condition.
T
he  skin  has  evolved  as  a  highly  developed 
organ  acting  as  a  barrier  between  the 
internal milieu of the body and the external 
environment. As a complex, self-renewing structure 
it plays a significant role in preventing excess water 
loss from the body, while preventing the ingress of 
noxious  physical,  chemical  and  biological  agents 
such  as  bacteria.  In  order  to  fulfil  this  role,  the 
skin undertakes a complex physiological process to 
maintain what has been termed the “skin barrier” 
(Elias, 1981). 
The  epidermis  is  organised  into  five  layers. 
The main cell of the epidermis, the keratinocyte, 
arises  from  the  stratum  basale  and  then  ascends 
the  epidermis  through  the  stratum  spinosum, 
granulosum,  and  finally  reaching  the  outermost 
layer, the stratum corneum. By the time cells have 
reached this layer, they have undergone a process of 
differentiation  transforming  into  dead,  anucleated 
flattened cells termed “corneocytes”. The outermost 
layer  of  the  epidermis,  the  stratum  corneum,  is 
where  the  barrier  function  occurs.  Cells  of  this 
layer are in close apposition, which is achieved by 
their high water content, keeping them turgid and 
in  close  physical  contact  with  the  adjacent  cells, 
forming a tight but flexible seal.
Turgidity of the cell is maintained by a chemical 
known as a “natural moisturising factor” (NMF) an 
intracellular  humectant  (a  substance  that  attracts 
water to itself; Cork, 1997). NMF is derived from 
a  substance  called  filaggrin,  which  breaks  down 
into  a  range  of  NMFs  including  urea,  amino-
acids,  pyrolidoncarboxylic  acid,  and  lactic  acid. 
Additionally,  this  maintains  a  constant  acidic  pH 
of  the  epidermis.  Locally,  the  barrier  is  enhanced 
by  lipid  layers  that  act  like  a  waterproof  mortar 
between  the  corneocytes.  These  lipids  originate 
from the lamellar bodies in the stratum granulosum 
and    are  secreted  into  the  epidermis  at  this  level 
forming sheets rich in ceramides, fatty acids, and 
cholesterol. 
Desquamation is maintained by the presence of 
epidermal proteases, which lyse corneodesmosomes 
and permit gradual shedding of the outermost layer 
of the epidermis. The action of proteases is limited 
by the low pH of the epidermis (around pH 5.5) 
and  protease  inhibitors  are  also  present  in  the 
skin. Ultimately the thickness of the epidermis is 
maintained by this chemical balance and pH (Cork 
and Danby, 2009). Consequently, the skin barrier is 
able to retain sufficient moisture to remain flexible 
and pliable. 
When  the  skin  barrier  fails  it  becomes  dry  (or 
“xerotic”;  Figure  1a),  scaly,  losses  elasticity,  and 
patients  may  complain  of  itching  or  stinging. 
Generally, it is considered a disease that is associated 
with ageing but there are many causes (Box 1) and 
for most patients it may be a combination of factors.
Physiological  dryness  is  common  in  both  the 
young  and  old,  particularly  in  women  following 
the  menopause.  With  ageing,  skin  turnover  slows 
– along with the production of NMFs – resulting 
in varying levels of dryness as the skin’s ability to 
retain water declines (Tagami, 2008). Emollients in the care of the diabetic foot
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Normal  bathing  and  washing  can  affect  skin 
barrier  function.  Bubble  bath,  soaps  (including 
moisturising brands), and shower gels can dry skin, 
particularly when applied vigorously or when they 
are  not  thoroughly  rinsed  from  the  skin  during 
bathing.  Moreover,  such  products  are  known  to 
raise  the  skin’s  pH  (Larson,  1999),  promoting  the 
activity of natural skin proteases, causing increased 
desquamation,  and  loss  of  skin  barrier  function. 
Product  additives  can  also  have  a  similar  effect; 
sodium  lauryl  sulphate  is  a  common  ingredient 
and is known to be an irritant and increases water 
loss through the epidermis (Tsang and Guy, 2010). 
Practices avoiding the use of soaps can be hazardous 
to the skin barrier – soaking in pure water for long 
periods  (>15–20  minutes)  can  have  a  significant 
drying effect (Bullus, 1998). 
Pathological dry skin occurs due to the effect of 
diseases which may reduce NMF production or alter 
the keratinisation process itself. Skin diseases are a 
prime example of xerosis as many exhibit dryness as 
part of their symptoms.
Skin  diseases  are  estimated  to  affect  between 
30%  and  100%  of  people  with  diabetes  (Bristow, 
2008).  Uncontrolled  hyperglycaemia  is  thought  to 
be responsible for an array of changes affecting the 
plantar  tissues,  including  stiffening  of  connective 
tissues,  abnormal  load  distribution,  and  increased 
susceptibility  to  infection  and  foot  ulceration 
(Pavicic and Korting, 2006). 
Many  surveys  of  dermatological  conditions  in 
people  with  diabetes  have  been  undertaken  and 
xerosis is commonly reported in people with diabetes, 
frequently concurrent with the symptoms of pruritis, 
fissur and callus formation (Figure 1b). Estimates in 
diabetic populations have been found to be as high as 
82% (Litzelman et al, 1997). However, research has 
not yet elucidate if the condition is more prevalent 
in  people  with  diabetes  than  those  without  as, 
undoubtedly,  the  causes  of  xerosis  in  people  with 
diabetes will share similar aetiologies to that of xerosis 
in those without the condition – particularly where 
common comorbidities associated with xerosis exist, 
such  as  psoriasis  (Armesto  et  al,  2012),  peripheral 
vascular disease (Faglia, 2011), renal failure (Bakris 
et al, 2000), and tinea pedis (Mayser et al, 2004). 
However, complex biochemical changes that result 
from  hyperglycaemia  in  diabetes  may  contribute 
to  the  development  of  xerosis  through  alternate 
pathways.  Autonomic  neuropathy  causing  vascular 
dysfunction reduces sweating on the foot, leading to 
epidermal dryness and fissuring (Vinik et al, 2003). 
In addition, skin elasticity is reduced in those with 
diabetes (Hashmi et al, 2006) with the deposition of 
advanced glycation end products (Aye and Masson, 
2002). Coupled with increased plantar pressures in 
people with diabetic (Veves et al, 1992), the diabetic 
foot is at increased risk of trauma and skin damage. 
Ultimately, an impaired skin barrier can increase the 
chances of bacterial infection (Bristow and Spruce, 
2009), a major risk factor for lower-limb amputation 
(Lavery et al, 2006).
Selection and benefits of  
emollient products 
Literature  on  emollient  selection  and  usage  is 
limited  and  often  not  evidence-based  (Hon  et  al, 
2013). Much of it is based on common practice and 
Physiological
•	Young or elderly
•	Menopause
•	Soaps, bubble baths and 
shower gels
•	Soaking the skin
•	Insufficient	rinsing	of	skin	
cleaning products
•	Vigorous drying with a 
towel
•	Over-bathing
•	Temperature & humidity 
– air conditioning and 
central heating
•	Sun exposure
Pathological
•	Many skin conditions 
e.g. eczema, psoriasis, 
ichthyosis
•	Skin infection
•	Peripheral vascular disease
•	Iron	deficiency	anaemia
•	Hypovitaminosis (A,B,C 
and E)
•	Renal failure
•	Diabetes
•	Thyroid disease
•	Anorexia nervosa
•	Lymphoma and other 
internal malignancies 
•	Drugs including statins, 
cimetidine, retinoids
Box 1. Causes of dry skin 
(xerosis) (Bristow, 2013).
Figure 1. Examples of (a) xerosis of the foot,  
and (b) heel fissures.
(a)
(b)Emollients in the care of the diabetic foot
The Diabetic Foot Journal Vol 16 No 2 2013  65
general consensus (Penzer, 2012), particularly in the 
management of dry skin conditions such as eczema 
and  psoriasis,  with  even  less  focussed  evidence 
available for dry skin on the diabetic foot. 
Emollients  are  known  to  be  effective  in  the 
management  of  dry  skin  (Proksch,  2008)  and 
are recommended as part of the routine foot care 
regimen  in  people  with  diabetes  (NICE,  2004). 
Research suggests that this may not only serve to 
improve  skin  quality  but  develop  a  preventative 
behaviour  for  detecting  early  diabetic  foot  lesions 
(Suico et al, 1998). As to which brand of emollient 
should be used, this should be a balance between 
patient preference and the available evidence for the 
specific condition being treated. 
An  emollient  (often  synonymously  called  a 
moisturiser)  has  a  number  of  functions;  it  soften 
and raise the moisture content within the epidermis, 
increase  the  skin’s  resistance  to  irritation  from 
outside agents, and improve pliability (Lodén, 2005). 
Emollient products contain a lipid base (fat, wax, or 
oil) with varying degrees of added water. Ointments 
tending to have the lowest water content through, 
with creams and gels having increased water content, 
while lotions have the lowest lipid content and, by 
their nature, feel lighter and less occlusive to the user 
(Bristow, 2013), although they have been shown to 
increase skin dryness through increased evaporation 
(Hon et al, 2013).
Not all emollients are the same and many have 
adjuvant  ingredients  to  enhance  efficacy.  Despite 
a  general  lack  of  evidence  in  the  effectiveness  of 
emollients,  much  has  been  documented  about  the 
additives urea and alphahydroxy acids (AHA), such 
as  ceramides,  glycolic,  and  lactic  acid  (Table  1). 
Early work suggested the effectiveness of urea-based 
products  (Van  Scott  and  Yu,  1974),  subsequently 
much  investigation  into  its  properties  has  been 
undertaken, with Locke et al (2012) undertaking a 
useful review of this literature. 
As  a  naturally  occurring  substance  within  the 
skin, research has demonstrated urea’s effectiveness 
at varying concentrations (5%–40%). Its ability to 
hold water within the epidermis (Cork and Danby, 
2009), have a keratolytic effect (i.e. thinning of the 
epidermis  without  reducing  water  retention),  and 
– as has been shown more recently – antimicrobial 
properties  (Grether-Beck  et  al,  2012),  have  been 
documented.  Recent  work  Lodén  et  al  (2013) 
demonstrated  a  15%  urea  formulation  rapidly 
improved dryness in the feet of people with diabetes, 
along with a measurable thinning of hyperkeratosis 
on the foot without detriment to the water retaining 
capacity of the epidermis. 
Lactic  acid,  another  naturally  occurring  lipid, 
has  also  been  shown  to  be  an  effective  emollient 
ingredient. Lactic acid has been shown to promote 
the  synthesis  of  ceramide  production  in  the  skin, 
improving barrier function, and reduce susceptibility 
to infection and irritation (Rawlings et al, 1996).
Dosages and application
General  guidance  on  emollients  suggests  that 
they should be applied frequently and can be used 
on  other  areas  of  unaffected  skin  safely  (Penzer, 
2012).  The  foot  presents  as  a  unique  area,  owing 
to  its  acral  location,  thick  plantar  epidermis  and 
footwear being worn for significant periods of time. 
It  has  been  recommended  that  heavier  emollients 
containing urea maybe more beneficial for the foot, 
and  application  of  products  just  prior  to  bedtime 
maybe  more  advantageous.  Application  of  the 
emollient to the foot, covering the foot with a damp 
under sock and then a dry over sock may enhance 
the  effectiveness  of  the  moisturisation  overnight 
and  prevent  soiling  of  bed  clothes  with  emollient 
products (Bristow, 2013). 
Emollients  available  in  pump  dispensers  are 
considered  to  be  more  user-friendly,  with  a  lower 
risk of contamination than traditional product tubs 
(Carr et al, 2008). Suggested dosages for a pair of 
feet are around 4–8 g per day of emollient (1 g being 
Brand Name  Constituents  Excipients
Aquadrate Cream  10% urea  None
Balneum Cream  5% urea, ceramide 1%.  Benzyl alcohol, polysorbates
Calmurid   10% urea, 5% lactic acid  None
Dermatonics Heel Balm   25% urea  Beeswax, lanolin
E45 Itch Relief  5% urea  Benzyl alcohol, polysorbates
Eucerin Intensive Cream  10% urea  Benzyl alcohol, isopropyl 
      palmitate, wool fat
Flexitol  25% urea  Benzyl alcohol, cetostearyl 
      alcohol, fragrance, lanolin
Hydromol Intensive  10% urea  None
Nutraplus  10% urea  Hydroxybenzoates (parabens),  
      propylene glycol
Table 1. Examples of emollient products containing urea and their excipients 
(British Medical Association and Royal Pharmaceutical Society, 2011).
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1. Literature on emollient selection 
and usage is limited and much 
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2. Emollients are known to be 
effective in the management 
of dry skin and are 
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equal to roughly a single “pump” from an emollient 
dispenser; Bristow, 2013). 
Adverse reactions to emollients are rare but can 
occasionally  occur  as  irritancy  or  allergy.  This  is 
most frequently caused by excipients within common 
emollient formulations. Table 1 highlights common 
additives  to  urea-based  emollient  preparations. 
Where a patient has a history of skin sensitivities, 
allergies or a history of eczema, a small area should 
be tested for a minimum of 48 hours before general 
use of any new emollient product (Penzer, 2012).
Conclusion
Dry skin (xerosis) on the foot is a common in people 
with  diabetes,  probably  due  to  a  combination  of 
factors.  The  use  of  emollients  can  improve  foot 
health  through  improving  skin  integrity  and  can 
also  serve  as  a  means  of  daily  foot  inspection  for 
people  with  diabetes  and  at-risk  feet.  It  is  likely 
that  any  emollient  applied  regularly  will  have  a 
positive impact on skin condition. Emollient choice 
should  be  primarily  be  based  on  patient  choice, 
in  consultation  with  their  healthcare  professional. 
Advice  on  how  to  use  them  should  also  be 
encouraged to ensure maximal effectiveness. Of the 
limited research into the most effective emollients for 
the diabetic foot to date has focussed on the benefits 
of using urea based products, which show positive 
benefits when compared to other emollients.  n 
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